Gordon B. Mills on the next revolution in cancer

October 10, 2017

Gordon B. Mills, M.D., Ph.D., is the new director of precision oncology at the OHSU Knight Cancer Institute. His role will be to provide an “integrative force” across various efforts in progress at the institute, including the Cancer Early Detection Advanced Research (CEDAR) Center, immuno-oncology and the system biology groups. In this video, Mills talks about the next revolution in cancer science.

Learn more about Mills.

More Stories

featured Eneida Nemecek, MD
featured Joshi Alumkal in Lab
09.07.18 | Cancer

Q&A with Joshi Alumkal, MD

Open House of Knight Cancer Research Building
09.17.18 | Cancer

A building with purpose

Onward E-News

Sign up to receive our latest campaign news, updates and stories in your inbox

loading animation